Company: OCEA
Filing Date: 2025-04-08
Form Type: 10-K
Source: 0001641172-25-003155
Chunk: 2578

Company: Ocean Biomedical, Inc.
Filing Date: 2025-04-08
Form: 10-K
Item: Item 1
Chunk 2578
---
 in substantial
dilution and decreases to our stock price.

73

It
is not possible to predict the actual number of shares of common stock, if any, we will sell under the Common Stock Purchase Agreement
to White Lion or the actual gross proceeds resulting from those sales.

Subject
to the satisfaction of certain customary conditions including, without limitation, the effectiveness of a registration statement to be
filed with the SEC registering the shares to be sold to White Lion for resale, our right to sell shares to White Lion will commence on
the effective date of that registration statement and extend for a period of two years thereafter. During such term, subject to the terms
and conditions of the Common Stock Purchase Agreement, we may notify White Lion when we exercise our right to sell shares.

We
generally have the right to control the timing and amount of any sales of our shares of common stock to White Lion under the Common Stock
Purchase Agreement. Sales of our shares of common stock, if any, to White Lion under the Common Stock Purchase Agreement will depend
upon market conditions and other factors to be determined by us. We may ultimately decide to sell to White Lion all, some or none of
the shares of common stock that may be available for us to sell to White Lion pursuant to the Common Stock Purchase Agreement.

Because
the purchase price per share of common stock to be paid by White Lion for the shares of common stock that we may elect to sell to White
Lion under the Common Stock Purchase Agreement, if any, will fluctuate based on the market prices of our common stock at the time we
elect to sell shares of common stock to White Lion pursuant to the Common Stock Purchase Agreement, if any, it is not possible for us
to predict, prior to any such sales, the number of shares of common stock that we will sell to White Lion under the Common Stock Purchase
Agreement, the purchase price per share that White Lion will pay for shares of common stock purchased from us under the Common Stock
Purchase Agreement, or the aggregate gross proceeds that we will receive from those purchases by White Lion under the Common Stock Purchase
Agreement.

The
number of shares of common stock ultimately offered for sale by White Lion is dependent upon the number of shares of common stock, if
any, we ultimately elect to sell to White Lion under the Common Stock Purchase Agreement. However, even if we elect to sell shares of
common stock to White Lion pursuant to the Common Stock Purchase Agreement, White Lion may resell all,